J Clin Psychiatry. 1999;60 Suppl 12:22-3.

A historical perspective of clozapine.

Source

Psychiatrische Klinik der Universität, Munich, Germany.

Abstract

Having challenged the established view that extrapyramidal symptoms are an intrinsic feature of antipsychotic activity, clozapine was developed as the first atypical antipsychotic with activity against both the positive and negative symptoms of schizophrenia. Following its partial withdrawal due to concerns over agranulocytosis, clozapine was reintroduced in response to pressure from psychiatrists and is now used worldwide in patients with treatment-resistant schizophrenia, having demonstrated its superiority over typical antipsychotic agents. This, combined with its low propensity to cause tardive dyskinesia, has transformed the management of patients with schizophrenia. This article outlines the history of clozapine's development, from its discovery in 1958 to its current position as the "gold standard" therapy for treatment-resistant schizophrenia.

PMID:: 10372606; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Historical Article

MeSH Terms

Substances

Clozapine

LinkOut - more resources

Medical

Schizophrenia - MedlinePlus Health Information

Molecular Biology Databases

CLOZAPINE - HSDB

Supplemental Content

Related citations

The history of clozapine and its emergence in the US market: a review and analysis. [Hist Psychiatry. 2007]
The history of clozapine and its emergence in the US market: a review and analysis.
Crilly J. Hist Psychiatry. 2007 Mar; 18(1):39-60.
Clozapine: current status and role in the pharmacotherapy of schizophrenia. [Can J Psychiatry. 1996]
Clozapine: current status and role in the pharmacotherapy of schizophrenia.
Remington GJ, Addington D, Collins EJ, Jones BD, Lalonde P, MacCrimmon DJ, MacEwan GW. Can J Psychiatry. 1996 Apr; 41(3):161-6.
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. [Am J Psychiatry. 2001]
Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Am J Psychiatry. 2001 Apr; 158(4):518-26.
Review Clozapine: a clinical review of adverse effects and management. [Ann Clin Psychiatry. 2003]
Review Clozapine: a clinical review of adverse effects and management.
Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM. Ann Clin Psychiatry. 2003 Mar; 15(1):33-48.
Review Starting clozapine in the community: a UK perspective. [CNS Drugs. 2004]
Review Starting clozapine in the community: a UK perspective.
O'Brien A. CNS Drugs. 2004; 18(13):845-52.

See reviews... See all...

Cited by 5 PubMed Central articles

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects. [Dialogues Clin Neurosci. 2004]
Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects.
Ackenheil M, Weber K. Dialogues Clin Neurosci. 2004 Mar; 6(1):71-7.
Review Group II metabotropic glutamate receptors and schizophrenia. [Cell Mol Life Sci. 2009]
Review Group II metabotropic glutamate receptors and schizophrenia.
Moreno JL, Sealfon SC, González-Maeso J. Cell Mol Life Sci. 2009 Dec; 66(23):3777-85. Epub 2009 Aug 26.
Review What do we know about neuropsychological aspects of schizophrenia? [Neuropsychol Rev. 2009]
Review What do we know about neuropsychological aspects of schizophrenia?
Palmer BW, Dawes SE, Heaton RK. Neuropsychol Rev. 2009 Sep; 19(3):365-84. Epub 2009 Jul 30.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A historical perspective of clozapine.
A historical perspective of clozapine.
J Clin Psychiatry. 1999 ;60 Suppl 12:22-3.

PubMed
Clozapine combined with different antipsychotic drugs for treatment resistant sc...
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Cochrane Database Syst Rev. 2009 Jul 8 ;(3):CD006324.

PubMed
Improved visualization of protein consensus sequences by iceLogo.
Improved visualization of protein consensus sequences by iceLogo.
Nat Methods. 2009 Nov ;6(11):786-7.

PubMed
Music therapy increases serum melatonin levels in patients with Alzheimer's dise...
Music therapy increases serum melatonin levels in patients with Alzheimer's disease.
Altern Ther Health Med. 1999 Nov ;5(6):49-57.

PubMed
Critique on the conceptualisation of quality of life: a review and evaluation of...
Critique on the conceptualisation of quality of life: a review and evaluation of different conceptual approaches.
Int J Nurs Stud. 2006 Sep ;43(7):891-901. Epub 2006 May 11 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: